| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kirstyn N Smith-LeCavalier, Paige M Morris, Mary E Larimer, Julia D Buckner, Katherine Walukevich-Diens. General and Domain-Specific Perceived Risk Demonstrate Unique Associations with Cannabis Use, Negative Outcomes, and Motivation to Change among Undergraduate Students. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883284. |
thus, among 130 undergraduates who reported past-month cannabis use, the present study conducted secondary analyses to test whether, for both perceived risk to others and perceived personal risk: (1) general perceived risk was associated with cannabis-related outcomes (i.e., use, negative consequences, cannabis use disorder (cud) symptoms, motivation to change), (2) seven specific domains of perceived risk were related to cannabis outcomes, and (3) domain-specific perceived risk was related to cannabis use frequency. |
2024-06-17 |
2024-06-19 |
human |
| Kirstyn N Smith-LeCavalier, Paige M Morris, Mary E Larimer, Julia D Buckner, Katherine Walukevich-Diens. General and Domain-Specific Perceived Risk Demonstrate Unique Associations with Cannabis Use, Negative Outcomes, and Motivation to Change among Undergraduate Students. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883284. |
general perceived risk to others was negatively associated with cannabis use frequency whereas general perceived personal risk was positively associated with cannabis-related negative consequences, cud symptoms, and importance and readiness to change. |
2024-06-17 |
2024-06-19 |
human |
| Renee Martin-Willett, Joshua S Elmore, Paige X Phillips, L Cinnamon Bidwel. Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions. Psychiatry and clinical psychopharmacology. vol 34. issue 1. 2024-06-17. PMID:38883882. |
based on the complication of these tools, 5 areas of potential development are highlighted to guide future research, including (i) sensitivity to the mode of cannabis administration as well as sensitivity to (ii) potency of cannabis products alongside frequency and quantity, (iii) unit equivalence, (iv) aligning clinical measures consistently with cannabis use disorder (cud) diagnostic criteria, and (v) creating measures specific to medical users, their motives for use, and their perceptions of therapeutic benefits or side effects. |
2024-06-17 |
2024-06-19 |
Not clear |
| Renee Martin-Willett, Joshua S Elmore, Paige X Phillips, L Cinnamon Bidwel. Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions. Psychiatry and clinical psychopharmacology. vol 34. issue 1. 2024-06-17. PMID:38883882. |
clinicians and researchers can pragmatically benefit from this summary of validated measures of cannabis use, and future work could improve the study of and clinical care for cannabis use and cud by pursuing one or more key areas of development described here. |
2024-06-17 |
2024-06-19 |
Not clear |
| Mark K Britton, Jason DeFelice, Eric C Porges, Ronald Cohen, Yancheng Li, Yan Wang, Gladys E Ibañez, Charurut Somboonwit, Robert L Coo. Association between cannabis use disorder and greater apathy in adults with HIV. Drug and alcohol dependence. vol 261. 2024-06-13. PMID:38870567. |
cannabis use and cannabis use disorder (cud) are also disproportionately prevalent among pwh. |
2024-06-13 |
2024-06-16 |
Not clear |
| Mark K Britton, Jason DeFelice, Eric C Porges, Ronald Cohen, Yancheng Li, Yan Wang, Gladys E Ibañez, Charurut Somboonwit, Robert L Coo. Association between cannabis use disorder and greater apathy in adults with HIV. Drug and alcohol dependence. vol 261. 2024-06-13. PMID:38870567. |
cud and younger onset of cannabis use may be linked to apathy in the general population; however, patterns of use most strongly associated with apathy have not been firmly established, and it is unclear whether cannabis use is linked to apathy in pwh. |
2024-06-13 |
2024-06-16 |
Not clear |
| Maha N Mian, Varada Sarovar, Tory Levine, Alexandra Lea, Amy Leibowitz, Mitchell Luu, Jason Flamm, C B Hare, Michael Horberg, Kelly Young-Wolff, Kristina Phillips, Michael Silverberg, Derek Satr. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. Research square. 2024-06-10. PMID:38853848. |
we examined factors associated with indicators risk for cannabis use disorder (cud) among pwh who used cannabis. |
2024-06-10 |
2024-06-14 |
human |
| Maha N Mian, Varada Sarovar, Tory Levine, Alexandra Lea, Amy Leibowitz, Mitchell Luu, Jason Flamm, C B Hare, Michael Horberg, Kelly Young-Wolff, Kristina Phillips, Michael Silverberg, Derek Satr. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. Research square. 2024-06-10. PMID:38853848. |
primary outcome was taps cannabis score (range 1-3), categorized as any use (1) and higher risk for cud (≥ 2). |
2024-06-10 |
2024-06-14 |
human |
| Youqian Zhang, Yue Su, Zitian Tang, Lin L. The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis. International journal of impotence research. 2024-06-04. PMID:38834872. |
this study utilized genome-wide association study (gwas) data to investigate the causal relationships between cannabis use disorder (cud), lifetime cannabis use (lcu), and ed, as well as levels of sex hormones including estradiol (e2), bioavailable testosterone (bt), follicle-stimulating hormone (fsh), and luteinizing hormone (lh) through mendelian randomization (mr) analysis. |
2024-06-04 |
2024-06-07 |
Not clear |
| Ardavan Mohammad Aghaei, Lia Urban Spillane, Brian Pittman, L Taylor Flynn, Joao P De Aquino, Anahita Bassir Nia, Mohini Ranganatha. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study. Psychopharmacology. 2024-06-04. PMID:38832949. |
recent reports have shown increased cannabis use among women, leading to growing concerns about cannabis use disorder (cud). |
2024-06-04 |
2024-06-06 |
human |
| Marco Bortolato, Giulia Braccagni, Casey A Pederson, Gabriele Floris, Paula J Fit. "Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression. Aggression and violent behavior. vol 78. 2024-06-03. PMID:38828012. |
this trend has shed light on a significant link between cannabis use disorder (cud) and pathological reactive aggression, a condition involving disproportionate aggressive and violent reactions to minor provocations. |
2024-06-03 |
2024-06-05 |
human |
| Abay Woday Tadesse, Getinet Ayano, Berihun Assefa Dachew, Kim Betts, Rosa Alat. Exposure to maternal cannabis use disorder and risk of autism spectrum disorder in offspring: A data linkage cohort study. Psychiatry research. vol 337. 2024-05-24. PMID:38788554. |
this study aimed to investigate the association between pre-pregnancy, prenatal and perinatal exposures to cannabis use disorder (cud) and the risk of autism spectrum disoder (asd) in offspring. |
2024-05-24 |
2024-05-27 |
Not clear |
| Cheng Ding, Dongdong Xu, Tao Chen. Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies. The Journal of the American Academy of Orthopaedic Surgeons. 2024-05-17. PMID:38759231. |
with the legalization of marijuana in the united states, the number of patients with cannabis use disorder (cud) in the joint arthroplasty population has increased markedly. |
2024-05-17 |
2024-05-27 |
Not clear |
| Sibylle Mauries, Geoffrey Dufayet, Ariane Lengereau, Michel Lejoyeux, Pierre A Geoffroy, Irène Dupon. Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review. Drug and alcohol dependence. vol 260. 2024-05-17. PMID:38759505. |
cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (cud): a systematic review. |
2024-05-17 |
2024-05-27 |
Not clear |
| Sibylle Mauries, Geoffrey Dufayet, Ariane Lengereau, Michel Lejoyeux, Pierre A Geoffroy, Irène Dupon. Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review. Drug and alcohol dependence. vol 260. 2024-05-17. PMID:38759505. |
cognitive-behavioral therapies (cbt) have emerged as a preferred approach for treating cannabis use disorders (cud) in adults. |
2024-05-17 |
2024-05-27 |
Not clear |
| Sarah DeGrace, Sean P Barrett, Igor Yakovenko, Philip G Tibbo, Pablo Romero-Sanchiz, R Nicholas Carleton, Thomas Snooks, Abraham Rudnick, Sherry H Stewar. Effects of Trauma Cue Exposure and Posttraumatic Stress Disorder (PTSD) on Affect and Cannabis Craving in Cannabis Users With Trauma Histories: Use of Expressive Writing as an Online Cue-Reactivity Paradigm: Effets de l'exposition aux signaux traumatiques et du SSPT sur l'affect et le besoin de cannabis chez les consommateurs de cannabis ayant des antécédents de traumatismes : utilisation de l'écriture expressive comme paradigme de réactivité en ligne. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2024-05-16. PMID:38751068. |
posttraumatic stress disorder (ptsd) and cannabis use disorder (cud) commonly co-occur. |
2024-05-16 |
2024-05-27 |
human |
| Tanja Legenbauer, Christiane Baldus, Carina Jörke, Lara Kaffke, Amra Pepic, Anne Daubmann, Antonia Zapf, Martin Holtmann, Nicolas Arnaud, Rainer Thomasiu. Mind it! A mindfulness-based group psychotherapy for substance use disorders in adolescent inpatients. European child & adolescent psychiatry. 2024-05-15. PMID:38748240. |
cannabis use disorder (cud) is the most frequent reason for psychiatric inpatient substance use disorder (sud) treatment among 15-19-year-olds in germany. |
2024-05-15 |
2024-05-27 |
human |
| Tanja Legenbauer, Christiane Baldus, Carina Jörke, Lara Kaffke, Amra Pepic, Anne Daubmann, Antonia Zapf, Martin Holtmann, Nicolas Arnaud, Rainer Thomasiu. Mind it! A mindfulness-based group psychotherapy for substance use disorders in adolescent inpatients. European child & adolescent psychiatry. 2024-05-15. PMID:38748240. |
as an add-on treatment to tau led to fewer cannabis use days after 6 months in 84 adolescent inpatients with cud. |
2024-05-15 |
2024-05-27 |
human |
| Sue O'Donnell, Kelly Scott-Storey, Jeannie Malcolm, Charlene D Vincent, Judith Wues. Cumulative lifetime violence, social determinants of health, and cannabis use disorder post-cannabis legalization in a community sample of men: An intersectional perspective. Research in nursing & health. 2024-05-09. PMID:38722053. |
despite canada having the highest disease burden globally for cannabis use disorder (cud) and violence being ubiquitous in men's lives, little is known about how intersections among social determinants of health (sdoh) and cumulative lifetime violence severity (clvs) influence cud in men post-cannabis legalization. |
2024-05-09 |
2024-05-27 |
Not clear |
| Sue O'Donnell, Kelly Scott-Storey, Jeannie Malcolm, Charlene D Vincent, Judith Wues. Cumulative lifetime violence, social determinants of health, and cannabis use disorder post-cannabis legalization in a community sample of men: An intersectional perspective. Research in nursing & health. 2024-05-09. PMID:38722053. |
chi-square tests showed significant intersection between adverse housing, younger age, profile 4 clvs, and moderate to severe cud among cannabis users. |
2024-05-09 |
2024-05-27 |
Not clear |